The immunologic mechanisms of EMT development in CRS are complex, and previous studies have shown that the immunoreactivity of TGF-β1, MAPK, Snail/Slug, and Smad2/3 was increased in the nasal mucosa of CRS patients [8,28]. This evidence concerns the gene TGFB1 and congenital rubella syndrome.